Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression

Z. Rónai, Reka Kovacs-Nagy, Eszter Szantai, Zsuzsanna Elek, M. Sasvári, G. Faludi, Judit Benkovits, J. Réthelyi, A. Székely

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The glycogen synthase kinase 3B (GSK3B) is an important target protein of several antidepressants, such as lithium, a mood stabilizer. Recent studies associated structural variations of the GSK3B gene to bipolar disorder (BP), although replications were not conclusive. Here we present data on copy number variations (CNVs) of the GSK3B gene probing the 9th exon region in 846 individuals (414 controls, 172 patients with major depressive disorder (MDD) and 260 with BP). A significant accumulation (odds ratio: 5.5, P=0.00051) of the amplified exon 9 region was found in patients (22 out of 432) compared to controls (4 of 414). Analyzing patient subgroups, GSK3B structural variants were found to be risk factors of BP particularly (P=0.00001) with an odds ratio of 8.1 while no such effect was shown in the MDD group. The highest odds (19.7 ratio) for bipolar disorder was observed in females with the amplified exon 9 region. A more detailed analysis of the identified GSK3B CNV by a set of probes covering the GSK3B gene and the adjacent NR1I2 and C3orf15 genes showed that the amplified sequences contained 3′ (downstream) segments of the GSK3B and NR1I2 genes but none of them involved the C3orf15 gene. Therefore, the copy number variation of the GSK3B gene could be described as a complex set of structural variants involving partial duplications and deletions, simultaneously. In summary, here we confirmed significant association of the GSK3B CNV and bipolar disorder pointing out that the copy number and extension of the CNV varies among individuals.

Original languageEnglish
Pages (from-to)217-222
Number of pages6
JournalAmerican Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
Volume165
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Glycogen Synthase Kinases
Bipolar Disorder
Genes
Exons
Odds Ratio
Major Depressive Disorder
Glycogen Synthase Kinase 3 beta
Lithium
Antidepressive Agents

Keywords

  • Bipolar depression
  • Copy number variation
  • Glycogen synthase kinase 3 beta
  • GSK3B
  • Major depression
  • Structural variants

ASJC Scopus subject areas

  • Genetics(clinical)
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Medicine(all)

Cite this

Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression. / Rónai, Z.; Kovacs-Nagy, Reka; Szantai, Eszter; Elek, Zsuzsanna; Sasvári, M.; Faludi, G.; Benkovits, Judit; Réthelyi, J.; Székely, A.

In: American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 165, No. 3, 2014, p. 217-222.

Research output: Contribution to journalArticle

@article{ffdb7234ac7f47ecb81175737403e430,
title = "Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression",
abstract = "The glycogen synthase kinase 3B (GSK3B) is an important target protein of several antidepressants, such as lithium, a mood stabilizer. Recent studies associated structural variations of the GSK3B gene to bipolar disorder (BP), although replications were not conclusive. Here we present data on copy number variations (CNVs) of the GSK3B gene probing the 9th exon region in 846 individuals (414 controls, 172 patients with major depressive disorder (MDD) and 260 with BP). A significant accumulation (odds ratio: 5.5, P=0.00051) of the amplified exon 9 region was found in patients (22 out of 432) compared to controls (4 of 414). Analyzing patient subgroups, GSK3B structural variants were found to be risk factors of BP particularly (P=0.00001) with an odds ratio of 8.1 while no such effect was shown in the MDD group. The highest odds (19.7 ratio) for bipolar disorder was observed in females with the amplified exon 9 region. A more detailed analysis of the identified GSK3B CNV by a set of probes covering the GSK3B gene and the adjacent NR1I2 and C3orf15 genes showed that the amplified sequences contained 3′ (downstream) segments of the GSK3B and NR1I2 genes but none of them involved the C3orf15 gene. Therefore, the copy number variation of the GSK3B gene could be described as a complex set of structural variants involving partial duplications and deletions, simultaneously. In summary, here we confirmed significant association of the GSK3B CNV and bipolar disorder pointing out that the copy number and extension of the CNV varies among individuals.",
keywords = "Bipolar depression, Copy number variation, Glycogen synthase kinase 3 beta, GSK3B, Major depression, Structural variants",
author = "Z. R{\'o}nai and Reka Kovacs-Nagy and Eszter Szantai and Zsuzsanna Elek and M. Sasv{\'a}ri and G. Faludi and Judit Benkovits and J. R{\'e}thelyi and A. Sz{\'e}kely",
year = "2014",
doi = "10.1002/ajmg.b.32223",
language = "English",
volume = "165",
pages = "217--222",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression

AU - Rónai, Z.

AU - Kovacs-Nagy, Reka

AU - Szantai, Eszter

AU - Elek, Zsuzsanna

AU - Sasvári, M.

AU - Faludi, G.

AU - Benkovits, Judit

AU - Réthelyi, J.

AU - Székely, A.

PY - 2014

Y1 - 2014

N2 - The glycogen synthase kinase 3B (GSK3B) is an important target protein of several antidepressants, such as lithium, a mood stabilizer. Recent studies associated structural variations of the GSK3B gene to bipolar disorder (BP), although replications were not conclusive. Here we present data on copy number variations (CNVs) of the GSK3B gene probing the 9th exon region in 846 individuals (414 controls, 172 patients with major depressive disorder (MDD) and 260 with BP). A significant accumulation (odds ratio: 5.5, P=0.00051) of the amplified exon 9 region was found in patients (22 out of 432) compared to controls (4 of 414). Analyzing patient subgroups, GSK3B structural variants were found to be risk factors of BP particularly (P=0.00001) with an odds ratio of 8.1 while no such effect was shown in the MDD group. The highest odds (19.7 ratio) for bipolar disorder was observed in females with the amplified exon 9 region. A more detailed analysis of the identified GSK3B CNV by a set of probes covering the GSK3B gene and the adjacent NR1I2 and C3orf15 genes showed that the amplified sequences contained 3′ (downstream) segments of the GSK3B and NR1I2 genes but none of them involved the C3orf15 gene. Therefore, the copy number variation of the GSK3B gene could be described as a complex set of structural variants involving partial duplications and deletions, simultaneously. In summary, here we confirmed significant association of the GSK3B CNV and bipolar disorder pointing out that the copy number and extension of the CNV varies among individuals.

AB - The glycogen synthase kinase 3B (GSK3B) is an important target protein of several antidepressants, such as lithium, a mood stabilizer. Recent studies associated structural variations of the GSK3B gene to bipolar disorder (BP), although replications were not conclusive. Here we present data on copy number variations (CNVs) of the GSK3B gene probing the 9th exon region in 846 individuals (414 controls, 172 patients with major depressive disorder (MDD) and 260 with BP). A significant accumulation (odds ratio: 5.5, P=0.00051) of the amplified exon 9 region was found in patients (22 out of 432) compared to controls (4 of 414). Analyzing patient subgroups, GSK3B structural variants were found to be risk factors of BP particularly (P=0.00001) with an odds ratio of 8.1 while no such effect was shown in the MDD group. The highest odds (19.7 ratio) for bipolar disorder was observed in females with the amplified exon 9 region. A more detailed analysis of the identified GSK3B CNV by a set of probes covering the GSK3B gene and the adjacent NR1I2 and C3orf15 genes showed that the amplified sequences contained 3′ (downstream) segments of the GSK3B and NR1I2 genes but none of them involved the C3orf15 gene. Therefore, the copy number variation of the GSK3B gene could be described as a complex set of structural variants involving partial duplications and deletions, simultaneously. In summary, here we confirmed significant association of the GSK3B CNV and bipolar disorder pointing out that the copy number and extension of the CNV varies among individuals.

KW - Bipolar depression

KW - Copy number variation

KW - Glycogen synthase kinase 3 beta

KW - GSK3B

KW - Major depression

KW - Structural variants

UR - http://www.scopus.com/inward/record.url?scp=84897480864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897480864&partnerID=8YFLogxK

U2 - 10.1002/ajmg.b.32223

DO - 10.1002/ajmg.b.32223

M3 - Article

C2 - 24677591

AN - SCOPUS:84897480864

VL - 165

SP - 217

EP - 222

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 3

ER -